Publication Details
Abstract
According to the World Health Organization, the COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused over 620 million infections and 6.5 million deaths worldwide as of September 2022 [1]. Over the past few years, the COVID-19 pandemic has had a significant impact on the health and lives of people around the world. Numerous retrospective studies have shown that age is a critical factor affecting the prognosis of patients with COVID-19 (Guan et al., 2020). Additionally, gender is believed to play an important role in the progression of COVID-19, as female patients have a better prognosis (Chen et al., 2020). Similarly, some infectious diseases, such as MERS and SARS, have mild clinical symptoms and better outcomes in women of childbearing age (Alghamdi et al., 2014; Karlberg et al., 2004). Researchers have been studying COVID-19 since day one, and there is already robust data on the effects of infection with the SARS-CoV-2 virus on the respiratory [2], circulatory [3] and nervous systems [4]. However, little is known about the impact of COVID-19 on the reproductive system, especially the female reproductive system. The impact of the COVID-19 pandemic on the female reproductive system and changes in the menstrual cycle have been widely reported anecdotally and in the media [5].